124 related articles for article (PubMed ID: 29157747)
21. Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy.
Katz A; Hanlon A; Lanciano R; Hoffman J; Coia L
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):393-6. PubMed ID: 9607356
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma.
Jiang W; Haque W; Verma V; Butler EB; Teh BS
Acta Oncol; 2019 Sep; 58(9):1259-1266. PubMed ID: 31237185
[No Abstract] [Full Text] [Related]
23. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.
de Geus SWL; Eskander MF; Kasumova GG; Ng SC; Kent TS; Mancias JD; Callery MP; Mahadevan A; Tseng JF
Cancer; 2017 Nov; 123(21):4158-4167. PubMed ID: 28708929
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.
Trovo M; Giaj-Levra N; Furlan C; Bortolin MT; Muraro E; Polesel J; Minatel E; Tedeschi R; Filippi AR; Alongi F; Ricardi U
Clin Transl Oncol; 2016 Oct; 18(10):1003-10. PubMed ID: 26687367
[TBL] [Abstract][Full Text] [Related]
25. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
[TBL] [Abstract][Full Text] [Related]
26. [Stereotactic body radiotherapy for locally advanced pancreatic cancer: A systemic review].
Tonneau M; Lacornerie T; Mirabel X; Pasquier D
Cancer Radiother; 2021 May; 25(3):283-295. PubMed ID: 33423968
[TBL] [Abstract][Full Text] [Related]
27. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer.
Lischalk JW; Burke A; Chew J; Elledge C; Gurka M; Marshall J; Pishvaian M; Collins S; Unger K
J Gastrointest Cancer; 2018 Jun; 49(2):116-123. PubMed ID: 28044263
[TBL] [Abstract][Full Text] [Related]
28. Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies.
Abi Jaoude J; Kouzy R; Nguyen ND; Lin D; Noticewala SS; Ludmir EB; Taniguchi CM
Curr Probl Cancer; 2020 Dec; 44(6):100607. PubMed ID: 32471736
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiation therapy in pancreatic cancer: the new frontier.
Moningi S; Marciscano AE; Rosati LM; Ng SK; Teboh Forbang R; Jackson J; Chang DT; Koong AC; Herman JM
Expert Rev Anticancer Ther; 2014 Dec; 14(12):1461-75. PubMed ID: 25183386
[TBL] [Abstract][Full Text] [Related]
30. Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival: A SEER Database Analysis.
Sajjad M; Batra S; Hoffe S; Kim R; Springett G; Mahipal A
Am J Clin Oncol; 2018 Mar; 41(3):236-241. PubMed ID: 26796313
[TBL] [Abstract][Full Text] [Related]
31. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions.
Myrehaug S; Sahgal A; Russo SM; Lo SS; Rosati LM; Mayr NA; Lock M; Small W; Dorth JA; Ellis RJ; Teh BS; Herman JM
Expert Rev Anticancer Ther; 2016 May; 16(5):523-30. PubMed ID: 26999329
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
Peixoto RD; Speers C; McGahan CE; Renouf DJ; Schaeffer DF; Kennecke HF
Cancer Med; 2015 Aug; 4(8):1171-7. PubMed ID: 25891650
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic Role of Pretreatment Neutrophil to Lymphocyte Ratio (NLR) in Malignant Adrenal Lesions Treated With Stereotactic Body Radiation Therapy (SBRT).
Mills MN; Reddy AV; Richardson L; Richardson KM; Kersh CR
Am J Clin Oncol; 2019 Dec; 42(12):945-950. PubMed ID: 31569166
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer.
Crane CH
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i53-i57. PubMed ID: 27029741
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience.
Jumeau R; Delouya G; Roberge D; Donath D; Béliveau-Nadeau D; Campeau MP
Dig Liver Dis; 2018 Apr; 50(4):396-400. PubMed ID: 29326012
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial.
Zhu X; Cao Y; Lu M; Zhao X; Jiang L; Ye Y; Ju X; Zhang H
Radiother Oncol; 2021 Sep; 162():178-184. PubMed ID: 34274393
[TBL] [Abstract][Full Text] [Related]
38. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer.
Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Prezzano KM; Hermann GM; Yu H; Singh AK
J Radiother Pract; 2022 Sep; 21(3):403-410. PubMed ID: 36016862
[TBL] [Abstract][Full Text] [Related]
39. Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).
Vernerey D; Huguet F; Vienot A; Goldstein D; Paget-Bailly S; Van Laethem JL; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Benetkiewicz M; Louvet C; Hammel P; Bonnetain F
Br J Cancer; 2016 Jul; 115(3):281-9. PubMed ID: 27404456
[TBL] [Abstract][Full Text] [Related]
40. Radiation as a Single-Modality Treatment in Localized Pancreatic Cancer.
Shaib WL; Zakka K; Shahin AA; Yared F; Switchenko JM; Wu C; Akce M; Alese OB; Patel PR; Mcdonald M; El-Rayes BF
Pancreas; 2020 Jul; 49(6):822-829. PubMed ID: 32541638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
